This website only uses technically necessary cookies. No tracking, no analytics.
Bio Protocol
BIO#486
$0.019174-2.14%
Bio Protocol (BIO) is a tradable crypto asset listed under the Bio Protocol name. It currently changes hands at $0.058897, carries a market capitalization of roughly $126.3 million, and sits at rank 253 by market cap. That puts BIO in the mid-sized tier of listed crypto assets — well outside the megacaps, but with enough scale to attract steady attention.
The headline figure in this Bio Protocol report is trading activity. Daily turnover comes in around $349.1 million, comfortably above the project's own market value. For active traders, that kind of liquidity makes BIO easier to follow when momentum shifts or short-term moves pick up speed. The flip side: price action driven by rapid rotation rather than slow accumulation, so judging an entry from market cap alone can be misleading.
Seen as a whole, BIO's profile right now is mostly a story of liquidity and valuation. You get a low nominal price, a nine-figure market cap, and unusually heavy reported daily turnover for an asset of this size. A practical caveat for any Bio Protocol analysis May readers run: heavy volume does not cancel out volatility — it can amplify it once sentiment turns. When weighing BIO against other assets, watch whether volume stays elevated, how its market-cap rank shifts over time, and whether the current price holds up during busier trading windows. Those signals matter for any realistic Bio Protocol forecast.
This content was created with the assistance of generative AI. Learn more
What is Bio Protocol? A quick explainer
Bio Protocol (BIO) is a crypto asset priced at $0.058897 with a market cap of about $126.3 million. Its 24-hour trading volume is high relative to its size, so newcomers should track volatility alongside price.
Security check
Smart contract risk scan — checks for honeypots, hidden taxes and more.
This coin carries 2 risk flags. Not suitable for beginners. If you invest anyway: only money you can afford to lose entirely. No DCA plans, no leverage, no FOMO buys after a pump.
AI analysis
Clear bullish / neutral / bearish signal based on market data, on-chain security and macro signals.
Analysis from November 10, 2026
This analysis is refreshed automatically in the background.
Rating
Bearish74% confident
Confidence
Summary
Bio Protocol's data paints a mostly strained picture right now. Yes, there are some reassuring smart-contract safeguards in place, and a visible base of locked or backed capital gives the project some footing — but the broader signals lean negative. The Fear & Greed Index, a widely-used gauge of overall crypto sentiment, sits at 32 (Fear), down two points from its seven-day starting level of 34. That tells you caution is still the dominant mood across the market. Security findings are a mixed bag: the code is open source and no honeypot behavior (a mechanism that traps holders and blocks them from selling) was flagged, yet the trust score lands at just 55/100, the contract allows new token creation, and the top ten wallet addresses control 61.37% of supply. Circulating supply stands at roughly 2.145 billion BIO out of a reported maximum of 3.32 billion — 64.61% already in the market. Put together, this coin analysis points to real concentration and supply-related risk, arriving at a moment when rising interest rates, persistent inflation, and a strengthening US dollar are already squeezing crypto assets broadly.
📰 Current News & Events
There's no current BIO-specific news to tie to its recent price behavior — nothing has surfaced that directly explains recent moves. The wider backdrop remains risk-averse: Fear & Greed sits at 32 (Fear), while the US policy interest rate, consumer-price inflation, and the Dollar Index are all climbing. Meanwhile, the top tracked stablecoins — tokens built to hold a steady value — total $256.8 billion, down 1.9% over seven days and 4.2% over 30 days within the measured scope. That's a useful snapshot of available capital in the system, but it doesn't tell us which way BIO itself is headed.
📈 Price Movement Analysis
The main price reference point for BIO remains its all-time high of $0.888995, set on January 3, 2025 — no recent percentage move is being claimed here. Rising rates, climbing inflation, and dollar strength together create a restrictive climate that tends to dampen appetite for speculative crypto assets. Only 64.61% of the reported maximum supply is currently circulating, though that fact alone doesn't confirm the remaining tokens are about to hit the market. The 61.37% concentration among the top ten addresses, combined with the contract's ability to mint new tokens, are both plausible channels for added volatility — but neither one proves what's actually driving any specific price swing.
Strengths
✅The contract is open source, meaning its code is publicly viewable for scrutiny, and it hasn't been flagged as a honeypot — a trap designed to stop users from exiting a token.
✅Transaction taxes sit at 0% both ways, and the contract shows no signs of transfer-pausing, trading cooldowns, adjustable slippage, hidden ownership, or blacklisting.
✅BIO has a presence across Ethereum, Solana, BNB Chain, and Base, and is positioned within the decentralized science space. That's a broad ecosystem footprint — though presence alone doesn't prove real adoption.
✅The project holds roughly $2.64 million in tracked TVL (total value locked or backed capital). That's a measurable base, but the dollar figure by itself doesn't confirm growing usage or fresh deposits.
Risks
⚠️The security trust score comes in at 55/100, and the contract is mintable — meaning its permissions allow additional tokens to be created at will.
⚠️The top ten addresses hold 61.37% of supply, pointing to significant concentration in a small number of wallets. The reported ~11,360 address count also doesn't equal the number of actual holders, since one person can control several addresses.
⚠️Roughly 35.39% of the maximum supply hasn't entered circulation yet, and no token-unlock schedule is available in current data coverage — leaving real uncertainty about when that supply might show up.
⚠️The macro climate remains tough for risk-sensitive assets: US rates, inflation, and the dollar are all rising while crypto sentiment stays stuck in Fear territory.
📊 Macro context
The Fear & Greed Index reads 32 (Fear), down from 34 at the start of the seven-day window — though it did recover from a weekly low of 25. Available history isn't deep enough to support a solid 90-day comparison here. Still, the current reading signals the market remains cautious rather than confident. The US policy interest rate climbed from 3.75% to 3.88%, consumer-price inflation rose from 3.71% to 4.02%, and the Dollar Index — which tracks the dollar against major currencies — ticked up from 121.5 to 121.9. No BIO-specific regulatory catalyst appears anywhere in the current event picture. Top tracked stablecoins total $256.8 billion, down 1.9% over seven days and 4.2% over 30 days within the defined scope. This is descriptive context only — it doesn't establish any particular direction for BIO.
❓ Frequently Asked Questions
Is Bio Protocol a good coin to invest in right now?
This coin analysis points to a predominantly strained picture. Fearful market sentiment, rising rates and inflation, contract mintability, and heavy address concentration outweigh the available positives. Open-source code, the absence of several dangerous contract controls, and measurable TVL offer some counterbalance, but not enough to offset the broader concerns — this is investment research (MiFID II Del. Reg 2017/565 Art. 36), not an investment recommendation (MAR Art. 3(35)).
Why is Bio Protocol's price moving the way it is?
No direct coin-specific cause can be pinned down here. The clearest pressure points in this coin forecast are the Fear & Greed reading of 32, rising rates, inflation, and dollar strength, layered on top of BIO's concentrated address structure and mintable contract design.
What are the biggest strengths and risks in this Bio Protocol market analysis?
On the plus side: open-source code, 0% transaction taxes, no detected honeypot behavior, and about $2.64 million in tracked locked or backed capital. On the risk side: a 55/100 trust score, 61.37% concentration among the top ten addresses, contract mintability, and the fact that only 64.61% of the reported maximum supply is currently circulating.
Bio Protocol's data profile right now is a study in contrasts: steady-but-modest protocol activity on one hand, concentration and security concerns on the other. Roughly $3.78 million is currently committed to the protocol, though that figure slipped 4.70% over the past seven days despite a 9.29% jump in the most recent 24 hours. Contract checks offer some reassurance — the code is open-source, transfers carry no transaction taxes, and the token isn't flagged as a honeypot — but the security score sits at a middling 55 out of 100. The Fear & Greed Index reads 65 (Greed), yet its slide from 73 to 65 over the week suggests market enthusiasm is cooling, which softens what would otherwise be a supportive sentiment signal. Risk concentration is also a factor: the ten largest addresses hold 59.62% of measured tokens. For anyone tracking BIO, uncertainty stays elevated since current price performance, on-chain flows, developer activity, and token-unlock timing simply aren't available yet.
Aug 27, 2026, 9:19 PM
BearishBearish · 77% confident
Bio Protocol's data picture leans heavily negative right now, largely because visible software development has stalled and several contract-related risks remain unresolved. The Fear & Greed Index sits at 71, in Greed territory, pointing to strong risk appetite across crypto — but that same enthusiasm raises the chance that sentiment has run ahead of fundamentals. Its seven-day trend actually slipped slightly, from 72 to 71. On the development side, tracked GitHub activity shows 0 commits, 0 merged pull requests, and no active contributors over the past four weeks. Add a security trust score of just 55, the contract's ability to mint additional tokens, and 59.57% concentration among the 10 largest wallets, and the uncertainty compounds further. Protocol deposits total roughly $4.02 million, with a 5.65% one-day recovery that stands in contrast to a 4.38% weekly decline. For anyone tracking BIO, missing price, on-chain flow, token-unlock, social-sentiment, and news data make this a harder coin analysis to verify — and that gap is exactly why confidence in a stronger conclusion stays limited.
Aug 20, 2026, 6:35 PM
NeutralNeutral · 78% confident
Bio Protocol's data tells two different stories at once. On one hand, deposits into the protocol are climbing fast. On the other, development activity has gone quiet and security indicators remain soft. The Fear & Greed Index — a widely-watched gauge of crypto market mood — sits at 62 (labeled 'Greed') after jumping 33 points from 29. That's a notable swing toward risk appetite, though such a fast move can also signal enthusiasm that hasn't been tested yet. Total value locked (TVL), the amount of capital deposited in the protocol, rose 14.44% in a single day and 20.56% over the past week, reaching roughly $4.18 million. That progress is tempered by a security trust score of just 55, heavy concentration with the ten largest holders controlling 59.49% of tokens, and zero recorded development activity over the past four weeks. Current price changes, project news, on-chain flows, social sentiment, and token-unlock details are all unavailable right now, which limits how far this coin analysis can go. For anyone tracking BIO, the takeaway is straightforward: sentiment and deposit growth look encouraging, but token-specific risks are real and thinly documented. This is investment research (MiFID II Del. Reg 2017/565 Art. 36), not investment advice.
